How has been the historical performance of SMS Pharma.?

Jul 14 2025 10:34 PM IST
share
Share Via
SMS Pharma has shown significant growth in net sales and profits, with net sales rising from 522.05 Cr in Mar'23 to 782.75 Cr in Mar'25, and net profit recovering from -7.06 Cr to 69.14 Cr during the same period, indicating strong operational efficiency and enhanced shareholder value.
Answer:
The historical performance of SMS Pharma shows a significant upward trend in net sales and profits over the past few years.

Breakdown:
SMS Pharma's net sales increased from 522.05 Cr in Mar'23 to 782.75 Cr in Mar'25, reflecting a strong growth trajectory. The total operating income followed a similar pattern, rising from 522.05 Cr in Mar'23 to 782.75 Cr in Mar'25. The company's total expenditure also grew, from 467.57 Cr in Mar'23 to 643.75 Cr in Mar'25, driven primarily by higher raw material costs, which increased from 299.72 Cr in Mar'23 to 501.87 Cr in Mar'25. Operating profit, excluding other income, rose from 54.48 Cr in Mar'23 to 139.00 Cr in Mar'25, indicating improved operational efficiency. Profit before tax surged from 5.35 Cr in Mar'23 to 92.34 Cr in Mar'25, while profit after tax increased from 3.88 Cr in Mar'23 to 67.40 Cr in Mar'25. The net profit also showed a remarkable recovery, moving from -7.06 Cr in Mar'23 to 69.14 Cr in Mar'25. Earnings per share (EPS) improved significantly, from -0.83 in Mar'23 to 7.79 in Mar'25, demonstrating the company's enhanced profitability and shareholder value. Overall, SMS Pharma's financial performance indicates a robust recovery and growth in both revenue and profitability over the analyzed period.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
SMS Pharmaceuticals Hits New 52-Week High at Rs.335.25
Nov 27 2025 09:53 AM IST
share
Share Via
SMS Pharmaceuticals Hits New 52-Week High at Rs.335.25
Nov 27 2025 09:53 AM IST
share
Share Via
Is SMS Pharma. overvalued or undervalued?
Nov 27 2025 08:25 AM IST
share
Share Via
Why is SMS Pharma. falling/rising?
Nov 27 2025 12:26 AM IST
share
Share Via
Most Read
Why is Odigma Consultan falling/rising?
4 hours ago
share
Share Via
Why is Premium Plast falling/rising?
4 hours ago
share
Share Via
Why is Afcons Infrastr. falling/rising?
4 hours ago
share
Share Via
Why is Bikewo Green falling/rising?
4 hours ago
share
Share Via
Why is Quest Laborato. falling/rising?
4 hours ago
share
Share Via
Why is Kataria Indust. falling/rising?
4 hours ago
share
Share Via
Why is Vishwas Agri falling/rising?
4 hours ago
share
Share Via